đ° Accelerate Commercialization News
Page 2 - Accelerate Commercialization News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Accelerate Commercialization. Real-time updates on events, politics, business and more.
March 5, 2021
As the U.S. locks up supplies to make Pfizer's COVID-19 vaccine, Serum Institute of India and WHO are raising flags about global supply bottlenecks and raw materials shortfalls, Bloomberg reports. The supply disruption comes after the Biden administration tapped the Defense Production Act to increase deliveries of Pfizer's shot in the U.S.
March 4, 2021
Takedas latest sale brings its total divestment value up to about $12.9 billion. (Takeda) After inking a slate of geography-specific product selloffs last year, Takeda has turned back to Japan. Takeda locked up a deal to sell four Type 2 diabetes meds in Japan to local drugmaker Teijin Pharma for 133 billion Japanese yen ($1.2 billion), freeing up the company to focus on its core businesses in gastroenterology, rare diseases, plasma-derived therapies, oncology and neuroscience. The move is the ...
March 4, 2021
Mar 4, 2021 10:54am The FDA has expanded Pfizers Lorbrena approval to include front-line ALK-positive non-small cell lung cancer. Pfizerâs Lorbrena has finally broken into front-line non-small cell lung cancer, where Novartis, Roche and Takeda are already jockeying for a niche market. The FDA expanded Lorbrenaâs use into newly diagnosed patients with ALK-positive NSCLC, Pfizer said Wednesday. With that front-line nod, the agency converted Lorbrenas conditional green light for previously tre...
March 4, 2021
Mar 4, 2021 11:33am Roche decided in 2015 to close four small-molecule manufacturing plants around the world. It found buyers for three. But the one that the company couldnt sell was in Clarecastle, Ireland. Destruction of the facility begins in June. (Roche) Unable to sell its plant in Clarecastle, Ireland, Roche will take a wrecking ball to the facility in June. It wonât be a simple process. In fact, a timeline of June 2021 to May 2028 has been listed for the project, which requires removi...
March 4, 2021
Mar 4, 2021 11:10am Biogen plans to bring on 90 new employees to staff its planned gene therapy manufacturing facility. (Biogen) As Biogen awaits an FDA decision on its controversial Alzheimers disease hopeful aducanumab, the company is setting the stage for an entry into the hot gene therapy field. Biogen has drawn up plans for a new gene therapy manufacturing facility at its Research Triangle Park campus in North Carolina. The 175,000-square-foot facility will be designed to scale up the...
March 3, 2021
Merck's "wartime" coronavirus tie-up with Johnson & Johnson puts the vaccine giant on deck to support drug substance, formulation and vial-filling work in the U.S. And the government is chipping in with $269 million to equip two Merck manufacturing plants for the work.
March 3, 2021
Mar 3, 2021 10:50am The FDA has sent a last-minute notification of an advisory committee review of FibroGen and AstraZenecas first-in-class anemia candidate roxadustat, threatening another decision delay. (FDA) FibroGen and AstraZeneca already endured a delay in the U.S. review of their anemia candidate roxadustat. Just as the pair was expecting to snag its first-in-class approval, as the revised date draws near, a capricious FDA has stunned the companies with a second blow. The FDA will conv...
March 3, 2021
Gilead Sciences plans to cut more than 170 jobs in California, as it builds a new business services center in North Carolina. The Foster City-based pharma will transfer about half of the jobs to the consolidated services hub now under construction in the Research Triangle Park area.
March 3, 2021
Mar 3, 2021 9:45am COVID-19 vaccine shipments are now underway. Here are the supply chains tasked with producing billions of doses. (nevodka/iStock/Getty Images Plus/Getty Images) As COVID-19 gained steam worldwide last spring, little was known about the disease and the havoc it would wreak on the world. A year later, vaccines offer hope in the fight against the virus, but it will be a monumental task to produce them and deliver them around the planet. That these vaccines were invented, put th...
March 3, 2021
Mar 3, 2021 12:19pm Novartis in February said it would convert manufacturing operations in Stein, Switzerland, into a life sciences hub focused on cell and gene therapy production. (Novartis) Like many CDMOs these days, Switzerlands Celonic aims to make a big splash in cell and gene therapyâand its picked up space at an emerging Novartis life sciences hub to take that work to the next level. Celonic sewed up a long-term lease for production and office space in the WST-222 building of Nov...